TSX News -
Saputo Inc. Announces a Change in Senior Management
MONTRÉAL, Dec. 23, 2024 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) announced today that Frank Guido […]
Aveanna to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team […]
Matador Adds Bitcoin to its Balance Sheet
TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA) is proud to announce […]
Comstock Fuels and Emerging Fuels Technology Advance SAF and Other Renewable Fuel Yields
VIRGINIA CITY, Nev., Dec. 23, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) announced today that […]
NextGen Digital Announces Listing on Frankfurt Stock Exchange
Fredericton, New Brunswick, Dec. 23, 2024 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (FSE:Z12) (“NextGen” or the “Company”) is […]
ParaZero Secured Major Australian Order for Drone Safety Systems, Strengthening Industry Leadership
Tel Aviv, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company or “ParaZero”), an aerospace […]
TeraWulf to Deliver over 70 MW of Data Center Infrastructure for G42’s US Operations
Core42, a Subsidiary of G42, will utilize the facility to expand its industry-leading AI Infrastructure offerings tailored to US customers […]
Enviri Corporation Names Christophe Reitemeier President, Harsco Environmental
A 25-year veteran of Harsco Environmental, Reitemeier previously served as CFO PHILADELPHIA, Dec. 23, 2024 (GLOBE NEWSWIRE) — Enviri Corporation […]
HUB Secures $7M In Debt Restructuring, Strengthening Financial Stability and Growth Trajectory
TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) — via IBN – HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or […]
RAPT Therapeutics Announces $150 Million Private Placement
SOUTH SAN FRANCISCO, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company […]
